What does Fiona H. Marshall invest in?

Fiona H. Marshall invests in Biotech.

Where did Fiona H. Marshall go to school?

Fiona H. Marshall studied at University of Cambridge (PhD, Neuroscience); University of Bath (BSc Hons, Biochemistry).

Fiona H. Marshall

Investor

President of Biomedical Research, Novartis at Novartis Venture Fund

Cambridge, Massachusetts, United States

Find your path to Fiona

429 people in our graph share verified history with Fiona — schools, employers, funds. One of them is your warm intro.

Simon LeveneunlockedFiona: together at University of Cambridge (1989)

Fiona: together at GSK

Fiona: together at University of Cambridge

×8Fiona: together at University of Bath

About

Fiona H. Marshall holds a PhD and serves as President of Biomedical Research at Novartis and sits on the company's Executive Committee, having joined in 2022. She previously led Discovery Sciences, Preclinical Development and Translational Medicine at MSD (Merck & Co.), and before that co-founded Heptares Therapeutics, where she was Chief Scientific Officer through its acquisition by Sosei. Earlier roles included Director of Molecular Pharmacology at Millennium Pharmaceuticals and senior positions at GSK; she earned a BSc in Biochemistry from the University of Bath and a PhD in Neuroscience from the University of Cambridge.

Invests in

Biotech

Experience

NovartisPresident, Biomedical Researchcurrent2022 — presentCambridge, Massachusetts, United States
MerckSenior Vice President Head of Discovery, Preclinical and Translational Medicine at Merck2021 — 2022Rahway, New Jersey, United States
MerckSenior Vice President Head of Discovery Sciences and Translational Medicine2021Rahway, New Jersey, United States
MerckVP Head of Neuroscience2019 — 2021West Point, Pennsylvania
MSDVP Head of Discovery Research MRL UK2018 — 2019London Area, United Kingdom
Sosei HeptaresExecutive Vice President and Chief Scientific Officer2015 — 2018
Sosei HeptaresChief Scientific Officer and Founder of Heptares Therapeutics2006 — 2018Welwyn Garden City
University of CambridgeVisiting Lecturer2002 — 2006Deptartments of Pharmacology and Chemical Engineeering
F.H.Marshall ConsultancyIndependent Consultant to Venture Capital and Biotech companies2002 — 2006
Millennium PharmaceuticalsDirector Biology Europe2000 — 2002Greater Cambridge Area
GSKHead of Molecular Pharmacology1998 — 2000Stevenage, England, United Kingdom
GSKHead of Receptor Systems Unit1995 — 1998Stevenage, England, United Kingdom
GlaxoGroup Leader Neuropharmacology1989 — 1994Ware, Hertfordshire, UK

Skills & more

Drug Discovery99Lifesciences40Pharmacology62Biotechnology64Protein Chemistry26Genomics12High Throughput Screening12Oncology10GPCRs21Drug Design10Cancer Research6Biomarker Discovery3

+9 more

Clinical TrialsIon ChannelsNeuropharmacologyMolecular PharmacologyDiabetesKinasesStrategyPharmaceuticsLife Sciences

From Fiona's professional profile.

Colleagues at Novartis Venture Fund

Adam Cotton

Principal at the Novartis Venture Fund

Anís

Head of Scoping, Pharma at Deep Science Ventures

Anja Koenig

Global Head of NVF at Novartis Venture Fund

Anja König

Global Head at Novartis Venture Fund

Bart Dzikowski

Managing Director, Head of Transactions & Legal at Novartis Venture Fund

Beat Steffen

Managing Director at Novartis Venture Fund

Campbell Murray

Advisor

Christoph Meier

Investor at Novartis Venture Fund

Frequently asked questions

Who is Fiona H. Marshall?: Fiona H. Marshall holds a PhD and serves as President of Biomedical Research at Novartis and sits on the company's Executive Committee, having joined in 2022. She previously led Discovery Sciences, Preclinical Development and Translational Medicine at MSD (Merck & Co.), and before that co-founded Heptares Therapeutics, where she was Chief Scientific Officer through its acquisition by Sosei. Earlier roles included Director of Molecular Pharmacology at Millennium Pharmaceuticals and senior positions at GSK; she earned a BSc in Biochemistry from the University of Bath and a PhD in Neuroscience from the University of Cambridge.
Where does Fiona H. Marshall work?: Fiona H. Marshall is President of Biomedical Research, Novartis at Novartis Venture Fund.
What does Fiona H. Marshall invest in?: Fiona H. Marshall invests in Biotech.
Where did Fiona H. Marshall go to school?: Fiona H. Marshall studied at University of Cambridge (PhD, Neuroscience); University of Bath (BSc Hons, Biochemistry).

Same school

Also attended University of Cambridge1,605

Stewart ButterfieldCo-founder of Slack and Flickr Demis HassabisCo-founder & CEO of Google DeepMind Niko BonatsosFounder and Managing Partner of Verdict Georgia StevensonInvestor at Index Ventures Hannah SealInvestor at Index Ventures Leah von SiemensPartner at Manta Ray Ventures

+ 1,599 more

Also attended University of Bath223

Catherine BergersenSenior Executive Assistant at Mayfair Equity Partners JohanInvestor at Investinor Maddie CoughlinInvestor at DN Capital Ben PalmerInvestment Professional at Oxx Juliette PetitChief of Staff at Keen Venture Partners Sarah HollyheadDirector at Marlin Equity Partners

+ 217 more

Shared employers

Also worked at Merck262

Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTech David MollerInvestor at Third Rock Ventures Alan EzekowitzInvestor at Third Rock Ventures Uri LopatinInvestor at Khosla Ventures

+ 256 more

Also worked at MSD20

Hiroshi TamadaChief Medical Officer at RDiscovery Ramy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures Sofia HasselbergInvestment Director at Bonnier Capital Isabella PhamInvestment Team at Five V Capital Khatereh AhmadiVenture Partner at XGEN Venture Michelle HohmannSenior HR Manager & Recruiter at Apollo Health Ventures

+ 14 more

Also worked at Sosei Heptares7

Anja KoenigGlobal Head of NVF at Novartis Venture Fund Bart DzikowskiManaging Director, Head of Transactions & Legal at Novartis Venture Fund Oliver WalkerManaging Partner at CGS Management AG Anja KönigGlobal Head at Novartis Venture Fund Kerrie L. BradyExecutive Officer at Centrexion Therapeutics David RoblinExecutive Officer at Summit Therapeutics

+ 1 more

Also worked at University of Cambridge285

Masha LevinVenture Partner at One Way Ventures Chris WeyrerPrincipal at Vida Ventures Annie DongInvestor at Dorm Room Francesco PomponiInvestor at Extantia Capital Jonathan RobinsonSenior Independent Director at EMV Capital Philip KalikmanAssistant Professor of Real Estate, Finance, & Economics at Joyance Partners

+ 279 more